The Follow-up of Mesh/Native Tissue Complications Study(Part II)
NCT ID: NCT03617211
Last Updated: 2018-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1530 participants
OBSERVATIONAL
2018-06-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multi-center Registry Study: The Follow-up the Complications for Trans-vaginal Mesh Surgery
NCT04025047
Comparison of Post-operative Symptoms After Two Surgeries for Patients With Pelvic Organ Prolapse
NCT05697796
Clinical Research on Bowel Symptoms of Patient With Pelvic Organ Prolapse
NCT02731391
Laparoscopic Sacral Colpopexy Versus Modified Total Pelvic Floor Reconstructive Surgery for Apical Prolapse Stage III-IV
NCT01762384
A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female
NCT03516266
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a study of real world. The researchers focus to investigate the incidence of complications in clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\) Pelvic reconstructive surgeries include but not limited to open/laparoscopic sacrocolpopexy (Y-shape tape/self-cut synthesized mesh), anterior, apical, posterior or total pelvic reconstruction with trans-vaginal mesh(commercial mesh kits or self-cut synthesized mesh), repair using native tissue(sacrospinous ligament fixation, high uterosacral ligament suspension, ischial spinous fascia fixation, the Lefort operation) and as well as anti-urinary incontinence surgeries(tension-free vaginal tape).
* 3\) Both primary and repeated pelvic surgery are included.
Exclusion Criteria
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University People's Hospital
OTHER
Qilu Hospital of Shandong University
OTHER
Obstetrics & Gynecology Hospital of Fudan University，Shanghai Red House Obstetrics & Gynecology Hospital
UNKNOWN
Peking University Third Hospital
OTHER
First Hospitals affiliated to the China PLA General Hospital
OTHER_GOV
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
OTHER
Tongji Hospital
OTHER
The First Affiliated Hospital of Guangzhou Medical University
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Wuxi Obsetrics & Gynecology Hospital
UNKNOWN
Fuzhou General Hospital
OTHER
The First Affiliated Hospital of Jinan Hospital
UNKNOWN
Women's Hospital School Of Medicine Zhejiang University
OTHER
Renmin Hospital of Wuhan University
OTHER
The Third Hospital Affiliated Zhengzhou University
UNKNOWN
Shengjing Hospital
OTHER
General Hospital of Ningxia Medical University
OTHER
The Second Hospital of Hebei Medical University
OTHER
Gansu Provincial Maternal and Child Health Care Hospital
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
Yantai Yuhuangding Hospital，Medical College, Qingdao University
UNKNOWN
Southwest Hospital, China
OTHER
West China Second University Hospital
OTHER
Jiangxi Maternal and Child Health Hospital
OTHER
Chongqing Medical University
OTHER
Shanxi Coal Central Hospital
UNKNOWN
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lan Zhu, MD
Role: PRINCIPAL_INVESTIGATOR
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of PLA General Hospital (304)
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Wuxi Obstetrics & Gynecology Hospital
Wuxi, Jiangsu, China
Obstetrics & Gynecology Hospital of Fudan University，Shanghai Red House Obstetrics & Gynecology Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ke Niu, MD
Role: primary
Yijuan Huang
Role: primary
Xiaojuan Wang, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-1566-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.